by last | Oct 5, 2021 | 2021, Past Events
Philogen participates at the BIO-Europe Digital 2021 BIO-Europe (informaconnect.com) – 2021, the international partnering event in the life science and pharma industry, on October 25-28, 2021 Please meet with us in case you are interested in a collaboration or...by last | Aug 23, 2021 | 2022, Press Releases
Philochem, a wholly owned subsidiary of Philogen S.p.A., InterX, Inc and Scripps Research announce a research collaboration to develop a best-in-class tumor targeting agent for metastatic prostate cancer.by last | Aug 23, 2021 | 2021, Press Releases
Philochem, a wholly owned subsidiary of Philogen S.p.A., InterX, Inc and Scripps Research announce a research collaboration to develop a best-in-class tumor targeting agent for metastatic prostate cancer. Philochem, InterX and Scripps Research...by last | Aug 23, 2021 | 2021, Press Releases, Scientific
Philochem, a wholly owned subsidiary of Philogen S.p.A., InterX, Inc and Scripps Research announce a research collaboration to develop a best-in-class tumor targeting agent for metastatic prostate cancer. Read Moreby last | Aug 6, 2021 | 2021, Past Events
Philogen has been invited to participate at the Eleventh Annual Biotech Symposium organised by Goldman Sachs on September 7, 2021. The aim of the Symposium is to provide an opportunity for investors to get a broader perspective of the current opportunity set that...